title: [Cholinesterase inhibitors for treating dementia. Review].
abstract: Alzheimer's disease is the most common form of dementia seen in the clinical practice. The principal risk factor is aging. There is not currently any available curative medication. However, there a family of drugs call the cholinesterase inhibitors (donepezile, galantamine and rivastigmine) the enhances cholinergic activity in the CNS. Also, memantine is available is a NMDA receptor modulator. A new transdermal way of administration is available now for rivastigmine. The rivastigmines patches are now a rational alternative focusing in getting more tolerance, better blood levels of the drug and compliance to treatment in Alzheimer's disease patients.
authors: Instituto Privado Kremer de Neuropsiquiatría Córdoba, Argentina. janus.kremer@institutokremer.com.ar
authors: Janus
authors: J
authors: Kremer